Production of Biologically Derived Pharmaceutical Starting Materials
Office of Assistant Secretary for Preparedness and Response · United States
Time Left to Bid
Awarded
Basic information
- Reference number
- 75A50124F61001
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- Production of Biologically Derived Pharmaceutical Starting Materials
- Source
- USASpending (Federal)
- Source ID
- usa-75A50124F61001
Details
- Location
- United States
Summary
Contract for producing three biologically derived small molecule regulatory starting materials and active pharmaceutical ingredients through the BIOMAP-Consortium. Involves commercial-scale pharmaceutical manufacturing for specialized medical materials.
Description
OTHER TRANSACTION: PRODUCTION OF THREE (3) BIOLOGICALLY DERIVED SMALL MOLECULE REGULATORY STARTING MATERIALS AND/OR ACTIVE PHARMACEUTICAL INGREDIENTS AT COMMERCIAL SCALE UNDER THE BIOMAP-CONSORTIUM Awarded to: ADVANCED TECHNOLOGY INTERNATIONAL Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DELIVERY ORDER
Dates
- Publication
- 2023/12/12 12:00:00 AM UTC
- Closing date
- 2027/12/31 12:00:00 AM UTC
Estimated value
$32.0M USD
Classification
Normalized category